Prevalencia de los factores de riesgo y estratificación del riesgo cardiovascular mediante la aplicación de las escalas Framingham, PROCAM, ASCVD y SCORE2 en individuos de estratos socioeconómicos 1, 2 y 3 atendidos en el programa de riesgo cardiovascular de la IPS Mired en Barranquilla, en 2021

Padilla Vega, Gabriel Felipe; Rojas Mancilla, Jairo Alberto

Prevalencia de los factores de riesgo y estratificación del riesgo cardiovascular mediante la aplicación de las escalas Framingham, PROCAM, ASCVD y SCORE2 en individuos de estratos socioeconómicos 1, 2 y 3 atendidos en el programa de riesgo cardiovascular de la IPS Mired en Barranquilla, en 2021

dc.contributor.advisor	Navarro Baene, Gina
dc.contributor.advisor	Bermúdez Daza, Emilio de Jesús
dc.contributor.author	Padilla Vega, Gabriel Felipe
dc.contributor.author	Rojas Mancilla, Jairo Alberto
dc.coverage.spatial	Barranquilla	spa
dc.creator.email	g.padillavega@gmail.com	spa
dc.creator.email	jairorojasm@gmail.com	spa
dc.date.accessioned	2023-02-06T15:22:14Z
dc.date.available	2023-02-06T15:22:14Z
dc.date.created	2022-06
dc.description.abstract	Objetivo: Determinar la prevalencia de los factores de riesgo cardiovasculares y estratificar el riesgo cardiovascular mediante la aplicación de los scores de Framigham, PROCAM, ASCVD y SCORE2. Materiales y métodos: Se realizó un estudio descriptivo, longitudinal y retrospectivo, en el que se incluyeron pacientes mayores de 18 años, pertenecientes a los estratos socioeconómicos 1, 2 y 3 atendidos en el programa de riesgo cardiovascular de MiRed IPS. Resultados: La muestra estuvo representada por 278 pacientes. El sexo femenino predominó en un 79,9% con una edad de 55 años, peso 73.6, talla 159 cm, IMC 29. Los factores de riesgo más prevalentes fueron: Sobrepeso/obesidad, síndrome metabólico, sedentarismo, dieta no saludable, colesterol total elevado, colesterol LDL elevado y colesterol HDL disminuido en un 75.8%, 67.9%, 67.2%, 65.6%, 58.4%, 37.7% y 19% respectivamente. La estratificaciones del riesgo según los modelos predictores fueron: Framigham riesgo alto, moderado y bajo, 32.5%, 49.2% y 18.4% respectivamente. PROCAM riesgo alto y no alto, 4.3% y 95.7% respectivamente. ASCVD riesgo alto, moderado, borderline y bajo, 19%, 34.1%, 11.8% y 35.1% respectivamente. SCORE2 riesgo muy alto, alto y bajo-moderado, 6.9%, 37.7% y 55.4% respectivamente. En el subgrupo de individuos mayores de 70 años según SCORE2 el 52.5% tuvo una clasificación de alto riesgo. Conclusiones: Los pacientes pertenecientes a la población vulnerable de bajo nivel socioeconómico presentan una alta prevalencia de Sobrepeso, Obesidad, Síndrome metabólico, sedentarismo, dieta no saludable, Hipercolesterolemia y Colesterol HDL disminuido asociado a un perfil de alto riesgo cardiovascular al aplicarse los modelos predictores de Framigham, ASCVD y SCORE2.	spa
dc.description.abstractenglish	Objective: To determine the prevalence of cardiovascular risk factors and stratify cardiovascular risk by applying the Framingham, PROCAM, ASCVD and SCORE2 scores. Materials and methods: A descriptive, longitudinal and retrospective study was carried out, which included patients over 18 years of age, belonging to socioeconomic level 1, 2 and 3 treated in the MiRed IPS cardiovascular risk program. Results: The sample was represented by 278 patients. The female sex prevailed in 79.9% with an age of 55 years, weight 73.6, height 159 cm, BMI 29. The most prevalent risk factors were: Overweight/obesity, metabolic syndrome, sedentary lifestyle, unhealthy diet, total cholesterol elevated, elevated LDL cholesterol, and decreased HDL cholesterol by 75.8%, 67.9%, 67.2%, 65.6%, 58.4%, 37.7%, and 19%, respectively. The risk stratifications according to the predictive models were: Framingham high, moderate and low risk, 32.5%, 49.2% and 18.4%, respectively. PROCAM high and non-high risk, 4.3% and 95.7%, respectively. ASCVD high, moderate, borderline and low risk, 19%, 34.1%, 11.8% and 35.1% respectively. SCORE2 very high, high and low-moderate risk, 6.9%, 37.7% and 55.4% respectively. In the subgroup of individuals older than 70 years according to SCORE2, 52.5% had a high-risk classification. Conclusions: Patients belonging to the vulnerable population of low socioeconomic status have a high prevalence of overweight, obesity, metabolic syndrome, sedentary lifestyle, unhealthy diet, hypercholesterolemia and decreased HDL cholesterol associated with a high cardiovascular risk profile when applying the predictive models of Framingham, ASCVD, and SCORE2.	spa
dc.description.sponsorship	Universidad Libre Seccional Barranquilla -- Facultad de Ciencias de la Salud -- Especialización en Medicina Interna	spa
dc.format	PDF	spa
dc.identifier.uri	https://hdl.handle.net/10901/24252
dc.relation.references	Cardiovascular diseases (CVDs) [Internet]. Who.int. 2021 [citado 15 marzo 2021]. Disponible en: https://www.who.int/news-room/factsheets/detail/cardiovascular-diseases-(cvds)	spa
dc.relation.references	Enfermedad cardiovascular principal causa de muerte en Colombia, boletín No 1 observatorio nacional de salud. Instituto nacional de salud. Bogotá. 09 diciembre 2013. [Actualización: 2013 Dic 09. citado: 15 marzo 2021]. Disponible en: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/IA/INS/ Boletin-tecnico-1-ONS.pdf	spa
dc.relation.references	Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study [published correction appears in Circulation 2002 Feb 19;105(7):900]. Circulation. 2002;105(3):310-315. doi:10.1161/hc0302.102575	spa
dc.relation.references	Grundy SM, Pasternak R, Greenland P, Smith S Jr, Fuster V. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation. 1999;100(13):1481-1492. doi:10.1161/01.cir.100.13.1481	spa
dc.relation.references	Jackson R. Updated New Zealand cardiovascular disease risk-benefit prediction guide [published correction appears in BMJ 2000 Dec 9;321(7274):1454]. BMJ. 2000;320(7236):709-710. doi:10.1136/bmj.320.7236.709	spa
dc.relation.references	Alvarado, Camilo, Molina, Dora I, Zárate, Alejandro & Toro, Esteban. (2014). Estudio EPRAS: estudio poblacional del riesgo cardiovascular de una población colombiana. Revista Colombiana de Cardiología, 21 (5), 284-293. https://doi.org/10.1016/j.rccar.2014.06.003	spa
dc.relation.references	Alvarado, Camilo, Jaramillo, Mónica, Matijasevic, Eugenio, Rendón, Iván D, & Quitian, Jerson. (2012). Estudio poblacional de factores de riesgo cardiovascular relacionados con el estilo de vida, búsqueda electrocardiográfica y medicación actual de pacientes valorados por el servicio de Cardiología. Revista Colombiana de Cardiología, 19 (2), 61- 71	spa
dc.relation.references	Ramírez, Robinson y Agredo, Ricardo A. (2012). El sedentarismo es un factor predictor de hipertrigliceridemia, obesidad central y sobrepeso. Revista Colombiana de Cardiología, 19 (2), 75-79. Disponible en: http://www.scielo.org.co/scielo	spa
dc.relation.references	Martín-Baranera, M., Campo, C., Coca, A., de la Figuera, M., Marín, R., Ruilope, L. M., & en representación del Grupo de Investigadores DICOPRESS (2007). Estratificación y grado de control del riesgo cardiovascular en la población hipertensa española. Resultados del estudio DICOPRESS [Stratification and degree of control of cardiovascular risk factors in hypertensive Spanish population. Results of the DICOPRESS study]. Medicina clinica, 129(7), 247–251. https://doi.org/10.1157/13108347	spa
dc.relation.references	Banegas JR, Segura J, Ruilope LM, Luque M, García-Robles R, Campo C, et al., CLUE Study Group Investigators. Blood pressure control and physician management of hypertension in hospital hypertension units in Spain. Hypertension. 2004;43:1338---44	spa
dc.relation.references	Villar J, Granados C, Torres G, Pérez J, Valencia L, Vélez C. Guía de práctica clínica Hipertensión arterial primaria (hta) [internet] abril 2013 [Citado 15 marzo 2021] Disponible en: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/INEC/I ETS/GPC_Completa_HTA.pdf	spa
dc.relation.references	Burt, B.A., Definitions of Risk. Journal of Dental Education, 65: 1007-1008. doi:10.1002/j.0022-0337.2001.65.10. tb03442	spa
dc.relation.references	Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines [published correction appears in Hypertension. 2018 jun;71(6):e136-e139] [published correction appears in Hypertension. 2018 Sep;72(3):e33]. Hypertension. 2018;71(6):1269- 1324. doi:10.1161/HYP.0000000000000066	spa
dc.relation.references	Brown DW, Giles WH, Greenlund KJ. Blood pressure parameters and risk of fatal stroke, NHANES II mortality study. Am J Hypertens. 2007;20(3):338-341. doi:10.1016/j.amjhyper.2006.08.004	spa
dc.relation.references	Lawes CM, Rodgers A, Bennett DA, Parag V, Suh I, Ueshima H, MacMahon S, Asia Pacific Cohort Studies Collaboration. Blood pressure and cardiovascular disease in the Asia Pacific region. J Hypertens. 2003;21:707–716	spa
dc.relation.references	Piano MR, Benowitz NL, Fitzgerald GA, et al. Impact of smokeless tobacco products on cardiovascular disease: implications for policy, prevention, and treatment: a policy statement from the American Heart Association. Circulation. 2010;122(15):1520-1544. doi:10.1161/CIR.0b013e3181f432c3	spa
dc.relation.references	Farzadfar F, Finucane MM, Danaei G, et al. National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3·0 million participants. Lancet. 2011;377(9765):578-586. doi:10.1016/S0140-6736(10)62038-7	spa
dc.relation.references	Fang H, Berg E, Cheng X, Shen W. How to best assess abdominal obesity. Curr Opin Clin Nutr Metab Care. 2018;21(5):360-365. doi:10.1097/MCO.0000000000000485	spa
dc.relation.references	GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1223- 1249. doi:10.1016/S0140-6736(20)30752-2	spa
dc.relation.references	Bachmann J., Willis B., Ayers C., Khera A., Berry J. Association Between Family History and Coronary Heart Disease Death Across Long-Term Follow-Up in Men, The Cooper Center Longitudinal Study. Circulation. 2012;125:3092–3098	spa
dc.relation.references	Münzel T, Sørensen M, Gori T, et al. Environmental stressors and cardiometabolic disease: part I-epidemiologic evidence supporting a role for noise and air pollution and effects of mitigation strategies. Eur Heart J. 2017;38(8):550-556. doi:10.1093/eurheartj/ehw269	spa
dc.relation.references	Lloyd-Jones, D. M., Huffman, M. D., Karmali, K. N., Sanghavi, D. M., Wright, J. S., Pelser, C., Gulati, M., Masoudi, F. A., & Goff, D. C., Jr (2017). Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients: The Million Hearts Longitudinal ASCVD Risk Assessment Tool: A Special Report From the American Heart Association and American College of Cardiology. Circulation, 135(13),e793–e813. https://doi.org/10.1161/CIR.0000000000000467	spa
dc.relation.references	R. Conroy, K. Pyörälä, A.P. Fitzgerald, S. Sans, A. Menotti, G. de Backer, SCORE project group, et al Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J., 24 (2003), pp. 987-1003	spa
dc.relation.references	M.T. Cooney, R. Selmer, A. Lindman, A. Tverdal, A. Menotti, T. Thomsen, et al. Cardiovascular risk estimation in older persons: SCORE O.P. Eur J Prev Cardiol., 23 (2016), pp. 1093-1103	spa
dc.relation.references	Ministerio de la Protección Social. Informe sobre la situación de salud en Colombia -Indicadores de salud 2018. [Internet]. Ministerio de la Protección Social. Colombia. 2018. [citado: 15 marzo 2021]. Disponible en: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/DE/PS/ sala-situacional-discapacidad-junio-2018.pdf	spa
dc.relation.references	Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the Management Of Arterial Hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36:1953–2041	spa
dc.relation.references	Sánchez Z, Camacho L, Sanchez S, Hernández H. Prevalencia de hipertensión arterial en Colombia: Revisión sistemática y metaanálisis. Acta Médica Colombiana,2019. 44(4). https://doi.org/10.36104/amc.2019.1293	spa
dc.relation.references	Kollia N, Panagiotakos DB, Georgousopoulou E, et al. Exploring the association between low socioeconomic status and cardiovascular disease risk in healthy Greeks, in the years of financial crisis (2002-2012): The ATTICA study. Int J Cardiol. 2016;223:758-763. doi:10.1016/j.ijcard.2016.08.294	spa
dc.relation.references	Zhang Y, Chen C, Pan X, Guo J, Li Y, Franco O H et al. Associations of healthy lifestyle and socioeconomic status with mortality and incident cardiovascular disease: two prospective cohort studies BMJ 2021; 373 :n604 doi:10.1136/bmj.n604	spa
dc.relation.references	Quispe R, Benziger CP, Bazo-Alvarez JC, et al. The Relationship Between Socioeconomic Status and CV Risk Factors: The CRONICAS Cohort Study of Peruvian Adults. Glob Heart. 2016;11(1):121-130.e2. doi:10.1016/j.gheart.2015.12.005	spa
dc.relation.references	Álvarez-Fernández C, Vaquero-Abellán M, Ruíz-Gandara Á, RomeroSaldaña M, Álvarez-López C. Factores de riesgo cardiovascular en la población en situación de riesgo de pobreza y exclusión social [Cardiovascular risk factors in the population at risk of poverty and social exclusión]. Aten Primaria. 2017;49(3):140-149. doi:10.1016/j.aprim.2016.05.009	spa
dc.relation.references	González M., Dennis J., Devia J., Echeverri D., Briceño G., Gil F., et al . Factores de riesgo cardiovascular y de enfermedades crónicas en población caficultora. Rev. salud pública [Internet]. 2012 June [cited 2022 June 13] ; 14( 3 ): 390-403. Disponible en: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0124- 00642012000300003&lng=en	spa
dc.relation.references	Gutiérrez-Perez R., Zuluaga-Londoño N., Gallego-López F,. Factores de riesgo cardiovascular en una población cafetera del Departamento de Caldas. Rev. salud pública [Internet]. 2017 Dec [cited 2022 June 13] ; 19( 6 ): 749-753. Disponible en: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0124006420 17000600749&lng=en	spa
dc.relation.references	Colorado J, Chaverra Z. Factores de riesgo cardiovascular, en las docentes adscritas a la cooperativa del magisterio del Chocó, en la ciudad de Quibdó, 2009. Año de publicación 2010, disponible en: https://repositorioslatinoamericanos.uchile.cl/handle/2250/78751	spa
dc.relation.references	Tsuji M, Arima H, Ohkubo T, et al. Socioeconomic Status and Knowledge of Cardiovascular Risk Factors: NIPPON DATA2010. J Epidemiol. 2018;28 Suppl 3(Suppl 3):S46-S52. doi:10.2188/jea.JE20170255	spa
dc.relation.references	Departamento Administrativo Nacional de Estadísticas [Internet]. Encuesta nacional de consumo de sustancias psicoactivas. [Consultado: 10 Jun 2022]. Disponible en: https://www.dane.gov.co/index.php/estadisticas-portema/salud/encuesta-nacional-de-consumo-de-sustancias-psicoactivasencspa	spa
dc.relation.references	Hessel P, Rodríguez-Lesmes P, Torres D. Socio-economic inequalities in high blood pressure and additional risk factors for cardiovascular disease among older individuals in Colombia: Results from a nationally representative study. PLoS One. 2020;15(6):e0234326. Published 2020 Jun 9. doi:10.1371/journal.pone.0234326	spa
dc.relation.references	Silva FACCD, Bragança MLBM, Bettiol H, Cardoso VC, Barbieri MA, Silva AAMD. Socioeconomic status and cardiovascular risk factors in young adults: a cross-sectional analysis of a Brazilian birth cohort. Rev Bras Epidemiol. 2020;23:e200001. Published 2020 Feb 21. doi:10.1590/1980- 549720200001	spa
dc.relation.references	Espírito Santo LR, Faria TO, Silva CSO, et al. Socioeconomic status and education level are associated with dyslipidemia in adults not taking lipidlowering medication: a population-based study [published online ahead of print, 2019 Nov 6]. Int Health. 2019;ihz089. doi:10.1093/inthealth/ihz089	spa
dc.relation.references	Camacho PA, Gomez-Arbelaez D, Otero J, et al. Self-Reported Prevalence of Chronic Non-Communicable Diseases in Relation to Socioeconomic and Educational Factors in Colombia: A CommunityBased Study in 11 Departments. Glob Heart. 2020;15(1):35. Published 2020 Apr 21. doi:10.5334/gh.792	spa
dc.relation.references	Kengne, Andre. (2013). The ADVANCE cardiovascular risk model and current strategies for cardiovascular disease risk evaluation in people with diabetes. Cardiovascular journal of Africa. 24. 376-381. 10.5830/CVJA2013-078	spa
dc.relation.references	Laffin LJ, Kaufman HW, Chen Z, et al. Rise in Blood Pressure Observed Among US Adults During the COVID-19 Pandemic. Circulation. 2022;145(3):235-237. doi:10.1161/CIRCULATIONAHA.121.057075	spa
dc.relation.references	Unger T, Borghi C, Charchar F, et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020;75(6):1334-1357. doi:10.1161/HYPERTENSIONAHA.120.15026	spa
dc.relation.references	Sabaté E.Adherence to long-term therapies: evidence for action. World Health Organization. Geneva. 2003	spa
dc.relation.references	Kulkarni S, Rao R, Goodman JDH, Connolly K, O'Shaughnessy KM. Nonadherence to antihypertensive medications amongst patients with uncontrolled hypertension: A retrospective study. Medicine (Baltimore). 2021;100(14):e24654. doi:10.1097/MD.0000000000024654	spa
dc.relation.references	Li ECK, Heran BS, Wright JM. Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension. Cochrane Database of Systematic Reviews 2014, Issue 8. Art. No.: CD009096. DOI: 10.1002/14651858.CD009096.pub2	spa
dc.relation.references	Zheutlin AR, Mondesir FL, Derington CG, et al. Analysis of Therapeutic Inertia and Race and Ethnicity in the Systolic Blood Pressure Intervention Trial: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open. 2022;5(1):e2143001. doi:10.1001/jamanetworkopen.2021.43001	spa
dc.relation.references	van Halm VP, Peters MJ, Voskuyl AE, et al. Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation. Ann Rheum Dis. 2009;68(9):1395-1400. doi:10.1136/ard.2008.094151	spa
dc.relation.references	Agca R, Heslinga SC, Rollefstad S, et al. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis. 2017;76(1):17-28. doi:10.1136/annrheumdis2016-209775	spa
dc.relation.references	Siwek M, Woroń J, Gorostowicz A, Wordliczek J. Adverse effects of interactions between antipsychotics and medications used in the treatment of cardiovascular disorders. Pharmacol Rep. 2020;72(2):350- 359. doi:10.1007/s43440-020-00058-6	spa
dc.relation.references	Correll CU, Solmi M, Veronese N, Bortolato B, Rosson S, Santonastaso P, et al. Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls. World Psychiatry. 2017;16(2):163–80	spa
dc.relation.references	Levinger N, Beykin G, Grunin M, et al. Socioeconomic status and visual outcome in patients with neovascular age-related macular degeneration. Eur J Ophthalmol. 2021;31(3):1094-1100. doi:10.1177/1120672120920783	spa
dc.relation.references	Gutiérrez Fernández M, Carrasco de Andrés D, Salmerón Febres LM, González Herrera L, Jiménez Brobeil S. Impact of socioeconomic status on the clinical profile of patients with non-traumatic lower-limb amputation. Cir Esp (Engl Ed). 2021;99(1):55-61. doi:10.1016/j.ciresp.2019.12.005	spa
dc.relation.references	Cuende JI. Vascular Age Versus Cardiovascular Risk: Clarifying Concepts. Rev Esp Cardiol (Engl Ed). 2016;69(3):243-246. doi:10.1016/j.rec.2015.10.019	spa
dc.relation.references	Álvarez Cosmea A., López Fernández V., Prieto Díaz M. A., Díaz González L., Herrero Puente P., Vázquez Álvarez J. et al . PROCAM y Framingham por categorías: ¿miden igual riesgo?. Medifam [Internet]. 2002 Abr [citado 2022 Jun 13] ; 12( 4 ): 40-49. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1131- 57682002000400003&lng=es	spa
dc.relation.references	Sung J, Song YM, Hong KP. Relationship between the shift of socioeconomic status and cardiovascular mortality. Eur J Prev Cardiol. 2020;27(7):749-757. doi:10.1177/2047487319856125	spa
dc.rights.accessrights	info:eu-repo/semantics/openAccess	spa
dc.rights.coar	http://purl.org/coar/access_right/c_abf2	spa
dc.rights.license	Atribución-NoComercial-SinDerivadas 2.5 Colombia	*
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/2.5/co/	*
dc.subject	Prevalencia	spa
dc.subject	Factores de riesgo cardiovascular	spa
dc.subject	Bajo nivel socioeconómico	spa
dc.subject	Framigham	spa
dc.subject	PROCAM	spa
dc.subject	ASCVD	spa
dc.subject	SCORE2	spa
dc.subject.lemb	Enfermedad coronaria	spa
dc.subject.lemb	Enfermos - Situación socioeconómica	spa
dc.subject.lemb	Síndrome metabólico	spa
dc.subject.lemb	Obesidad	spa
dc.subject.lemb	Muestreo	spa
dc.subject.subjectenglish	Prevalence	spa
dc.subject.subjectenglish	Cardiovascular risk factors	spa
dc.subject.subjectenglish	Low socioeconomic level	spa
dc.subject.subjectenglish	Framingham	spa
dc.subject.subjectenglish	PROCAM	spa
dc.subject.subjectenglish	ASCVD	spa
dc.subject.subjectenglish	SCORE2	spa
dc.title	Prevalencia de los factores de riesgo y estratificación del riesgo cardiovascular mediante la aplicación de las escalas Framingham, PROCAM, ASCVD y SCORE2 en individuos de estratos socioeconómicos 1, 2 y 3 atendidos en el programa de riesgo cardiovascular de la IPS Mired en Barranquilla, en 2021	spa
dc.type.coar	http://purl.org/coar/resource_type/c_7a1f	spa
dc.type.driver	info:eu-repo/semantics/bachelorThesis	spa
dc.type.hasversion	info:eu-repo/semantics/acceptedVersion	spa
dc.type.local	Tesis de Especialización	spa